Lana Pine is the editor of HCPLive Rheumatology. She is an experienced editor and technical writer with a demonstrated history of working in the banking and publishing industries. In her free time, she enjoys cooking, yoga, listening to podcasts, and drawing. She can be reached via email at LPine@mjhlifesciences.com.
Inclusive Trials, Informed Treatments: Prioritizing Diversity in Clinical Research
May 11th 2024As disparate representation in pivotal research impacts the outcomes of common diseases like lupus, clinicians and researchers alike are working to foster trust and collaboration with more patients of color.
Read More
Only 20% of Patients with Fibromyalgia Report Receiving Satisfactory Information on Pain
May 7th 2024Pain relief and healthcare satisfaction were significantly increased in patients who were educated about their fibromyalgia and received care from a knowledgeable clinician who gave them information and guidance.
Read More
FDA Approves High-Concentrate, Citrate-Free Formulation of Biosimilar Adalimumab-adbm
May 1st 2024The current approval is based on the VOLTAIRE-HCLF clinical trial, which examined the bioavailability of high-concentration (100 mg/mL) and low-concentration (50 mg/mL) formulations of adalimumab-adbm.
Read More